
Oncologist

No OPD information available
Ascites
Histiocytosis
Langerhans Cell Histiocytosis
Reticulohistiocytoma
Acute Interstitial Pneumonia
ADULT Syndrome
Astrocytoma
Breast Cancer
Glioblastoma
Glioma
George Kannourakis is a male medical professional who helps people with different health problems like Ascites, Histiocytosis, and Cancer. He is skilled in treating various conditions such as Langerhans Cell Histiocytosis and Glioblastoma. George is known for his expertise in dealing with complex diseases like Acute Interstitial Pneumonia and Astrocytoma.
Patients trust George Kannourakis because he communicates well with them. He explains medical things in a simple way that they can understand. Patients feel comfortable talking to him because he listens carefully to their concerns and answers their questions.
George Kannourakis stays updated on the latest medical information and research. This helps him provide the best care for his patients. He reads medical journals and attends conferences to learn about new treatments and technologies.
George works well with other medical professionals. He collaborates with colleagues to give patients the best possible care. By sharing knowledge and working together, they can help more people get better.
George Kannourakis has made a positive impact on many patients' lives. His treatments have helped people recover from serious illnesses like Glioma and Breast Cancer. Patients appreciate his dedication to improving their health and well-being.
One of George Kannourakis's notable publications is "The Role of TIM-3 in Glioblastoma Progression," which was published in Cells in January 2025. He has also been involved in clinical trials, such as the study on Tislelizumab for Esophageal Squamous Cell Carcinoma, which has helped advance medical knowledge and treatment options.
In summary, George Kannourakis is a caring and knowledgeable medical professional who works hard to help his patients and contribute to medical research. His dedication to staying informed, collaborating with colleagues, and making a positive impact on patients' lives sets him apart in the medical field.
Enrollment Status: Completed
Published: October 26, 2024
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
